Press releases

Advanced Search
  • Feb 4, 2014
    -- Raises the bottom end of full fiscal year 2014 revenue and earnings ranges for guidance.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the first fiscal quarter ended December 31, 2013,...

  • Feb 3, 2014
    Second quarter revenue increased to $922 million, driven by continued strength in the company's Procedural Solutions segment

    SAN DIEGO, CA, Feb. 3, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its second quarter of fiscal 2014,...

  • Jan 29, 2014
    CareFusion, Terumo Sign Distribution Agreement For IV Catheters

    SAN DIEGO, CA, Jan. 29, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, and Terumo Corporation, the largest medical technology company in Japan, today...

  • Jan 28, 2014

    The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on March 31, 2014 to holders of record on March...

  • Jan 14, 2014

    BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 28,...

  • Jan 13, 2014
    BD MAX(TM) MRSA XT Assay with eXTended Detection Technology Receives FDA Clearance

    BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has received FDA clearance to market the BD MAX(TM) MRSA XT

  • Jan 10, 2014

    SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release second quarter fiscal 2014 results on Monday, Feb. 3, following the close of...

  • Jan 9, 2014

    SAN DIEGO, CA, Jan. 9, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN) today issued the following statement regarding a previously disclosed settlement agreement: Today, the U.S. Department of...

  • Jan 7, 2014

    BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2014 earnings conference call on Tuesday, February 4, 2014, at 8:00...

  • Jan 7, 2014
    Advances BD Diagnostics' Point-of-Care Strategy

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired Alverix, Inc., a privately-held diagnostic instrument company...